ArticleJournal of orthopaedic case reports2025
Biochemical Markers Linking Osteoporosis and Cardiovascular Risk in Older Adults: A Retrospective Analysis.
Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Osteoporosis is a prevalent metabolic bone disorder, particularly affecting the elderly, and is often linked to cardiovascular morbidity. This study investigated the associations among osteoporosis, biochemical markers, bone mineral density (BMD), and cardiovascular disease (CVD). Materials and Methods: A cross-sectional analysis was conducted among 280 individuals diagnosed with osteoporosis and 182 without osteoporosis to assess the relationship between osteoporosis and serum levels of triglycerides, total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and homocysteine (HCY). Correlations between these biochemical indices and BMD were evaluated. CVD prevalence was compared between osteoporosis and non-osteoporosis groups, and receiver operating characteristic curve analysis was used to assess the predictive potential of BMD for CVD risk. Results: Higher triglyceride, TC, and LDL levels were positively associated with osteoporosis, while elevated HDL and HCY levels showed inverse associations. Triglyceride levels correlated negatively with BMD, whereas TC and HDL demonstrated positive correlations. LDL showed a weak negative association, and HCY exhibited a strong inverse correlation with BMD. Individuals with osteoporosis had lower BMD and a higher incidence of CVD compared to those without osteoporosis. Logistic regression confirmed that reduced BMD significantly increased cardiovascular risk. Conclusion: This study highlights significant associations among osteoporosis, lipid profiles, HCY levels, BMD, and CVD. The findings suggest that dyslipidemia and altered HCY metabolism may contribute to both bone loss and cardiovascular pathology. BMD may serve as a potential biomarker for identifying individuals at increased cardiovascular risk. Further longitudinal research is needed to establish causal relationships and assess long-term clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.